| Thu, Nov 5, 2009 | | • | Amylin To Live Large On The Fat Of The Land
at Forbes.com (Thu, Nov 5)
| | • | Placing Bets On Human Genome's Benlysta
Indie Research (Thu, Nov 5)
| | • | LILLY ELI & CO Financials
EDGAR Online Financials (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | An Ode to Schering-Plough
at Motley Fool (Wed, Nov 4)
| | • | Oncology On Canvas(SM) Launches 2010 Art Competition for Individuals Touched by Cancer
PR Newswire (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | [$$] Stock Picks for the Defensive Investor
at RealMoney by TheStreet.com (Tue, Nov 3)
| | • | Amylin Scores a Hat Trick
at Motley Fool (Tue, Nov 3)
| | • | Obamacare Positive To Net Neutral For Pharmaceutical Industry According To Analysis By Morningstar Expert
Wall Street Transcript (Tue, Nov 3)
| | • | [$$] A Tutorial in Defensive Investing
at Barrons.com (Tue, Nov 3)
| | • | Trading Outlook for Avanir Pharmaceuticals Inc. Issued by InvestorSoup.com
GlobeNewswire (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Takeda / Amylin
at FT.com (Mon, Nov 2)
| | • | Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase
Wall Street Transcript (Mon, Nov 2)
| | • | FDA adds kidney health warnings to Byetta label
AP (Mon, Nov 2)
| | • | Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDA's BYETTA(R) (Exenatide) Injection Update
PR Newswire (Mon, Nov 2)
| | • | CEO Interview, Cortex Pharmaceuticals, Inc. - Dr. Mark Varney
Wall Street Transcript (Mon, Nov 2)
| | • | Eli Lilly: Warming Up or Cooling Off?
at Motley Fool (Mon, Nov 2)
| | • | Trading Review for Cell Therapeutics Incorporated Issued by Beacon Equity
GlobeNewswire (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | • | BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
PR Newswire (Fri, Oct 30)
| | • | Shrugging Off the Side Effects
at Motley Fool (Fri, Oct 30)
| | • | Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'
PR Newswire (Fri, Oct 30)
| | • | It's Not As Frightening As It First Appears
at Motley Fool (Fri, Oct 30)
| | • | Of One-Time Gains and Pipelines
at Motley Fool (Fri, Oct 30)
| | • | LILLY ELI & CO Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Oct 30)
| | • | World's Scariest Stocks: Pfizer
at Motley Fool (Fri, Oct 30)
| | • | Some stocks with scary returns in 2008 are up big this year
at CNNMoney.com (Fri, Oct 30)
|
Add LLY News to My Yahoo!:
 
| |
|
0.02% Nasdaq 
0.33%
Headlines
